Zymeworks Inc.

General ticker "ZYME" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.1B (TTM average)

Zymeworks Inc. follows the US Stock Market performance with the rate: 49.1%.

Estimated limits based on current volatility of 3.3%: low 25.77$, high 27.14$

Factors to consider:

  • Total employees count: 294 as of 2022
  • Current price 45.4% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [9.24$, 18.24$]
  • 2025-12-31 to 2026-12-31 estimated range: [8.27$, 16.69$]

Financial Metrics affecting the ZYME estimates:

  • Negative: with PPE of -8.8 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -10.28 <= 0.33
  • Negative: negative Industry operating cash flow (median)
  • Positive: Inventory ratio change, % of -20.47 <= -0.75
  • Positive: Shareholder equity ratio, % of 73.15 > 63.39
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term ZYME quotes

Long-term ZYME plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $412.48MM $76.01MM $76.30MM
Operating Expenses $281.95MM $214.06MM $213.41MM
Operating Income $130.53MM $-138.05MM $-137.11MM
Non-Operating Income $4.71MM $18.81MM $20.50MM
R&D Expense $208.60MM $143.62MM $134.62MM
Income(Loss) $135.23MM $-119.24MM $-116.61MM
Taxes $10.89MM $-0.57MM $6.08MM
Profit(Loss)* $124.34MM $-118.67MM $-122.69MM
Stockholders Equity $492.96MM $464.81MM $338.77MM
Assets $648.73MM $580.88MM $463.09MM
Operating Cash Flow $144.11MM $-118.30MM $-110.04MM
Capital expenditure $13.12MM $4.08MM $3.07MM
Investing Cash Flow $-53.85MM $-207.25MM $38.76MM
Financing Cash Flow $108.58MM $81.85MM $-20.45MM
Earnings Per Share** $1.91 $-1.72 $-1.62

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.